Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss

Menopause

Volumn 18, Issue 6, 2011, Pages 690-697

  Zhao, Yu ^a   Huai, Yue ^a   Jin, Jie ^a   Geng, Mei ^a   Li, Jian Xin ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Apoptosis; Osteoclast; Osteoporosis; Ovariectomized mice; Quinoxaline derivative of oleanolic acid

Indexed keywords

ALENDRONIC ACID; CASPASE 3; ETHINYLESTRADIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLEANOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DENSITY; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOLYSIS; OVARIECTOMY; SHAM PROCEDURE;

ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MICE; OSTEOBLASTS; OSTEOCLASTS; OVARIECTOMY; QUINUCLIDINES;

EID: 79958813624     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181fd7f4b     Document Type: Article

References (31)

1. Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone 2006;38:4-9.
2. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis Int 2006;17: 1726-1733. (Pubitemid 44607392)
3. Simon LS. Osteoporosis. Clin Geriatr Med 2005;21:602-604.
4. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-342. (Pubitemid 40852708)
5. Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA 2001;285:1460-1465. (Pubitemid 32221894)
6. Vainio H, Weiderpass E. Hormone replacement therapy for symptoms but not for chemoprevention of chronic diseases. Asian Pac J Cancer Prev 2003;4:275-276.
7. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Post-menopausal hormone replacement therapyVscientific review. JAMA 2002;288:872-881.
8. He CC, Hui RR, Tezuka Y, Kadota S, Li JX. Osteoprotective effect of extract from Achyranthes bidentata in ovariectomized rats. J Ethnopharmacol 2010;127:229-234.
9. Li JX, Hareyama T, Tezuka Y, Zhang Y, Miyahara T, Kadota S. Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity on osteoclast formation. Planta Med 2005;71:673-679. (Pubitemid 41133079)
10. Li JF, Chen SJ, Zhao Y, Li JX. Glycoside modification of oleanolic acid derivatives as a novel class of anti-osteoclast formation agents. Carbohyd Res 2009;344:599-605.
11. Zhang Y, Li JX, Zhao JW, et al. Synthesis and activity of oleanolic acid derivatives, a novel class of inhibitors of osteoclast formation. Bioorg Med Chem Lett 2005;15:1629-1632. (Pubitemid 40312543)
12. Li JF, Zhao Y, Cai MM, Li XF, Li JX. Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity. Eur J Med Chem 2009;44:2796-2806.
13. Kim MH, Ryu SY, Choi JS, Min YK, Kim SH. Saurolactam inhibits osteoclast differentation and stimulates apoptosis of mature osteoclasts. J Cell Physiol 2009;221:618-628.
14. Kuo JHS, Jan MS, Chiu CHW, Lic CT. Cytotoxicity characterization of catanionic vesicles in RAW 264.7 murine macrophage-like cells. Colloid Surface B Biointerfaces 2005;41:189-196.
15. Jayaprakasam B, Zhang Y, Seeram NP, Nair MG. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci 2003;74:125-132. (Pubitemid 37324225)
16. Newbold RR, Jefferson WN, Padilla-Banks E, Walker VR, Pena DS. Cell response endpoints enhance sensitivity of the immature mouse uterotropic assay. Reprod Toxicol 2001;15:245-252. (Pubitemid 32552930)
17. Giner-Larza EM, Manez S, Recio MC, et al. Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity. Eur J Pharmacol 2001;428:137-143. (Pubitemid 32971767)
18. Hsu HY, Yang JJ, Lin CC. Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett 1997;111:7-13.
19. Jeong HG. Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol Lett 1999;105:215-222. (Pubitemid 29164491)
20. O'Brien CA. Control of RANKL gene expression. Bone 2010;46:911-919.
21. Miller K, Stenzl A, Tombal B. Advances in the therapy of prostate cancer-induced bone disease: current insights and future perspectives on the RANK/RANKL pathways. Eur Urol Suppl 2009;8:747-752.
22. Spencer GJ, Utting JC, Etheridge SL, Arnett TR, Genever PG. Wnt signalling in osteoblasts regulates expression of the receptor activator of NF kappa B ligand and inhibits osteoclastogenesis in vitro. J Cell Sci 2006; 119:1283-1296.
23. Lee SE, Woo KM, Kim SY, et al. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 2002;30:71-77. (Pubitemid 34044303)
24. 2+ accelerates nuclear translocation of nuclear factor J B in osteoclasts. J Biol Chem 2003; 278:8286-8293. (Pubitemid 36800575)
25. Jimi E, Shuto T, Koga T. Macrophage-colony-stimulating factor and interleukin-1> maintain the survival of osteoclast-like cells. Endocrinology 1995;136:808-811.
26. Vaananen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J Cell Sci 2000;113:377-381. (Pubitemid 30116644)
27. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289: 1504-1508.
28. Tanaka S, Wakeyama H, Akiyama T, et al. Regulation of osteoclast apoptosis by bcl-2 family protein bim and caspase-3. Adv Exp Med Biol 2010;658:111-116.
29. Emerton KB, Hu B, Woo AA, et al. Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. Bone 2010;46:577-583.
30. Canderelli R, Leccesse LA, Miller NL. Benefits of hormone replacement therapy in postmenopausal women. J Am Acad Nurse Pract 2007; 19:635-641.
31. McLeod KM, Johnson CS. Identifying women with low bone mass: a systematic review of screening tools. Geriatr Nur 2009;30:164-173.